NCT02815631View on ClinicalTrials.gov

Assessing the Efficacy of CARDIOgoniometry (CGM) to Determine Physiologically Significant Stenosis in Patients With Stable Coronary Artery Disease in Comparison to Fractional FLOW Reserve - CARDIOFLOW

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

October 1, 2016

Conditions
Coronary Artery Disease
Interventions
DEVICE

Cardiogoniometry (CGM)

DEVICE

Fractional Flow Reserve (FFR)

Trial Locations (1)

HU16 5JQ

Castle Hill Hospital, Hull

All Listed Sponsors
lead

Hull University Teaching Hospitals NHS Trust

OTHER_GOV

NCT02815631 - Assessing the Efficacy of CARDIOgoniometry (CGM) to Determine Physiologically Significant Stenosis in Patients With Stable Coronary Artery Disease in Comparison to Fractional FLOW Reserve - CARDIOFLOW | Biotech Hunter | Biotech Hunter